Usefulness of Soluble Concentrations of Interleukin Family Member ST2 as Predictor of Mortality in Patients With Acutely Decompensated Heart Failure Relative to Left Ventricular Ejection Fraction

This publication has 29 references indexed in Scilit:

• Interleukin-33 Prevents Apoptosis and Improves Survival After Experimental Myocardial Infarction Through ST2 Signaling
  Circulation: Heart Failure, 2009
• Complementary Prognostic Value of Cystatin C, N-Terminal Pro-B-Type Natriuretic Peptide and Cardiac Troponin T in Patients With Acute Heart Failure
  The American Journal of Cardiology, 2009
• Soluble ST2 Plasma Concentrations Predict 1-Year Mortality in Acutely Dyspneic Emergency Department Patients With Pulmonary Disease
  American Journal of Clinical Pathology, 2008
• Increased Plasma Concentrations of Soluble ST2 are Predictive for 1-Year Mortality in Patients with Acute Destabilized Heart Failure
  Clinical Chemistry, 2008
• Metoprolol Reverses Left Ventricular Remodeling in Patients With Asymptomatic Systolic Dysfunction
  Circulation, 2007
• IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system
  Journal of Clinical Investigation, 2007
• Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure
  Heart, 2005
• The N-terminal Pro-BNP Investigation of Dyspnea in the Emergency department (PRIDE) study
  The American Journal of Cardiology, 2005
• Effects of carvedilol on left ventricular regional wall motion in patients with heart failure caused by ischemic heart disease
  Journal of Cardiac Failure, 2000
• Crucial Role of the Interleukin 1 Receptor Family Member T1/St2 in T Helper Cell Type 2–Mediated Lung Mucosal Immune Responses
  The Journal of Experimental Medicine, 1999